✦ LIBER ✦

P953. Phase II study of taxotere® (Docetaxel, D), Doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)

✍ Scribed by J.-M. Nabholtz; J.R. Mackey; M. Smylie; A. Paterson; D. Noel; T. Al-Tweigeri; F. Delorme

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

650 - Taxotere™ (docetaxel, D), doxorubi

✍ J.-M. Nabholtz; M. Smyllo; J.R. Mackey; A. Paterson; D. Noel; T. Al-Twelgerl; D. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Final results of a phase II study of Tax

✍ J.-M. Nabholtz; J.R. Mackey; M. Simylie; A. Paterson; D. Noel; T. Al-Twelgeri; A 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Taxotere® (T) and doxorubicin (D) combin

✍ Vallejos, C.; Nunez, P.; Orlandi, L.; Carranza, H.; Fodor, M.; Reyes, J.M.; Majl 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

5075 POSTER Non-pegylated Liposomal Doxo

✍ Imperatori, L.; Lippe, P.; Trapuzzano, C.; Laid, G.; Cappelletti, C.; Tamburrano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase II study of weekly docetaxel (Taxo

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Phase I study of an all-oral combination

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB